PERNIX THERAPEUTICS HLDGS IN - COM (PTX)

CUSIP: 71426V108

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
16,907,801
Share change
+7,837,344
Total reported value
$86,684,966
Price per share
$5.35
Number of holders
58
Value change
+$38,526,112
Number of buys
37
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 71426V108?
CUSIP 71426V108 identifies PTX - PERNIX THERAPEUTICS HLDGS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM (PTX) as of Q1 2014

As of 31 Mar 2014, PERNIX THERAPEUTICS HLDGS IN - COM (PTX) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,907,801 shares. The largest 10 holders included Broadfin Capital, LLC, SAGEVIEW CAPITAL LP, ORBIMED ADVISORS LLC, F&C Asset Management plc, Consonance Capital Management LP, EDMUNDS WHITE PARTNERS LLC, JUPITER ASSET MANAGEMENT LTD, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and VANGUARD GROUP INC. This page lists 58 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.